Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.

The chicken embryo chorioallantoic membrane (CAM) is widely used as an in vivo model to study the vascular effects of angiogenesis modulating agents. The main goal of the present study was to develop and validate a quantitative method to characterize time-dependent changes mainly in the capillary network of the CAM. To that end, the CAM capillaries were monitored in ovo, between days 7 and 13 of embryo development, using an epi-fluorescence microscope equipped with a sensitive camera following the intravenous injection of a fluorescent agent. We present a method by which the fluorescence angiograms of the CAM vasculature were recorded and analyzed by a multistep mathematical procedure to obtain a skeleton representation of the vessels and capillaries. From this skeleton descriptors were extracted, including the number of branching points/mm(2), the mean area of the vessel network meshes, and the mean of the 3rd quartile of the mesh area histogram. A qualitative visual assessment of the vasculature based on the number and the size of the avascular zones was obtained for comparison. To illustrate this approach, the activity of a neutralizing anti-vascular endothelial growth factor antibody, Avastin (Bevacizumab), was then quantified. Blood vessel growth inhibition and changes in the architecture of the capillary plexus after topical application of this drug on the CAM surface were monitored using the three descriptors mentioned above.

[1]  J. Folkman,et al.  Protamine is an inhibitor of angiogenesis , 1982, Nature.

[2]  I. Maglogiannis,et al.  Automated Angiogenesis Quantification through advanced Image Processing Techniques , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[3]  Yan Gao,et al.  Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity. , 2006, Biochemical and biophysical research communications.

[4]  Terri L. McKay,et al.  A VEGF165-induced phenotypic switch from increased vessel density to increased vessel diameter and increased endothelial NOS activity. , 2006, Microvascular research.

[5]  Robert Gurny,et al.  The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. , 2007, Advanced drug delivery reviews.

[6]  G. Wagnières,et al.  Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne®), in the CAM model , 2008, Angiogenesis.

[7]  Ruslan Hlushchuk,et al.  Quantification of angiogenesis in the chicken chorioallantoic membrane (CAM) , 2011 .

[8]  I. Queguiner,et al.  Anti‐angiogenic properties of myo‐inositol trispyrophosphate in ovo and growth reduction of implanted glioma , 2007, FEBS letters.

[9]  S. Melmed,et al.  Human pituitary tumor-transforming gene induces angiogenesis. , 2001, The Journal of clinical endocrinology and metabolism.

[10]  D. Korbie,et al.  Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent. , 2004, Microvascular research.

[11]  J Baillie,et al.  Safety and efficacy of India ink and indocyanine green as colonic tattooing agents. , 2000, Gastrointestinal endoscopy.

[12]  Ganga Karunamuni,et al.  VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks , 2009, Anatomical record.

[13]  T H Adair,et al.  Morphometric measurements of chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia. , 1991, The American journal of physiology.

[14]  Terri L. McKay,et al.  Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide. , 2008, Investigative ophthalmology & visual science.

[15]  P. Hutchins,et al.  Hypoxia-induced angiogenesis in chick chorioallantoic membranes: a role for adenosine. , 1988, Respiration physiology.

[16]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[17]  Ws. Rasband.  ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA , 2011 .

[18]  Ilias Maglogiannis,et al.  Computer-Supported Angiogenesis Quantification Using Image Analysis and Statistical Averaging , 2008, IEEE Transactions on Information Technology in Biomedicine.

[19]  W. Risau,et al.  Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  S. Schmidt,et al.  Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis. , 1996, Microvascular research.

[21]  C. Roussos,et al.  Anti‐angiogenic properties of a sulindac analogue , 2007, British journal of pharmacology.

[22]  H. Bergh,et al.  A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. , 2001, Investigative ophthalmology & visual science.

[23]  Georges Wagnières,et al.  Vascular effects induced by anti-VEGF agents in the CAM model: effect of the DMSO , 2009, World Congress of the International Photodynamic Association.

[24]  P. Parsons-Wingerter,et al.  A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. , 1998, Microvascular research.

[25]  B. Christ,et al.  In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane , 1993, Cell and Tissue Research.

[26]  Pierre Corvol,et al.  Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. , 2004, Diabetes.

[27]  Anastasia J. Romanoff,et al.  Biochemistry of the avian embryo : a quantitative analysis of prenatal development , 1967 .